You are here: Industry Insights > acquire

News List

AbbVie signs agreement to acquire Irish Botox maker Allergan for $63bn pharmaceutical-technology
June 27, 2019
AbbVie has signed a definitive transaction agreement to acquire Irish Botox maker Allergan.
Pfizer to acquire US company Array BioPharma for $11.4bn pharmaceutical-technology
June 19, 2019
Pfizer has signed a definitive merger agreement to acquire US-based, commercial-stage biopharmaceutical company Array BioPharma.
Pfizer to acquire Array BioPharma in a $11.4B deal biospectrumasia
June 18, 2019
Proposed acquisition strengthens Pfizer’s innovative biopharmaceutical business and is expected to accelerate its growth trajectory particularly in the long term
Sobi to acquire emapalumab drug from Novimmune americanpharmaceuticalreview
June 14, 2019
Swedish Orphan Biovitrum (Sobi) has agreed to buy a newly established firm from Novimmune for a consideration of SEK4,897m ($517.9m).
SCHOTT AG to acquire Australian microfluidic expert MINIFAB biospectrumasia
June 13, 2019
Customers to benefit from complementary portfolio of top quality polymer and glass solutions for breakthrough diagnostics applications
Merck to acquire Tilos Therapeutics for $773m pharmaceutical-technology
June 13, 2019
Merck has signed an agreement to buy biopharmaceutical company Tilos Therapeutics for a total consideration of up to $773m.
Otsuka Chemical acquires Cefixime business of Astellas Pharma biospectrumasia
June 10, 2019
Aims to supply API (active pharmaceutical ingredient) to licensees abroad together with licensing company contracts and commercial brand which strengthens antibiotics integrated business from intermediaries to API
Amgen offers $167m to acquire Nuevolution pharmaceutical-technology
May 24, 2019
Amgen has made a public offer to buy Denmark-based biopharmaceutical company Nuevolution for a cash consideration of around $167m.
Evotec to acquire biologics company Just Biotherapeutics pharmaceutical-technology
May 23, 2019
Evotec has entered a definitive agreement to acquire Just Biotherapeutics and its in-house drug development technology platform J.DESIGN.
Merck to Acquire Peloton Therapeutics americanpharmaceuticalreview
May 22, 2019
Merck and Peloton Therapeutics announced the companies have entered into a definitive agreement under which Merck, throu

Previous page 1 2 3 4 5 Next page